Intelligence · Clinical Pipeline
Oncology · Phase II
Oncology programs at Phase II — ClinicalTrials.gov pipeline intelligence.
- Programs
- 2,640
Quick answer
Oncology Phase II programs: NovaPharmaNews indexes 2,640 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.
Top sponsors
- First People's Hospital 261 programs
- Chinese Academy of 199 programs
- George Institute for 119 programs
- United Therapeutics Europe 112 programs
- Telethon Foundation 91 programs
- Takeda 79 programs
- Regeneron UK 71 programs
- MSD Merck Sharp 63 programs
- Ningbo Cancer Hospital 62 programs
- Anaxis Pharma 57 programs
- AstraZeneca 52 programs
- HOFFMANN-LA ROCHE 50 programs
-
CETUXIMAB , MK-1084, MK-1084, MK-1084, MK-1084
Merck Sharp and Dohme
Neoplasm malignant with KRAS G12C mutation
1 trial -
CETUXIMAB, FOLINIC ACID, FLUOROURACIL, IRINOTECAN
Fondazione Telethon ETS
ADCC, Colorectal Cancer
1 trial -
CF102
Can-Fite BioPharma
Hepatocellular Carcinoma
2 trials -
CG0070
CG Oncology
Bladder Cancer
1 trial -
CG0070
CG Oncology
Non Muscle Invasive Bladder Cancer
1 trial -
CGT4859
Cogent Biosciences
Intrahepatic Cholangiocarcinoma (Icc)
1 trial -
CGT9486
Cogent Biosciences
Gastrointestinal Stromal Tumors
1 trial -
CHO-H01
Cho Pharma
Non-Hodgkin Lymphoma
1 trial -
CHOP+selinexor+5-Azacitidine
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Peripheral T Cell Lymphoma
1 trial -
CIALIS 5 mg film-coated tablets
The George Institute
sexual/ erectile function in women and men after treatment for rectal cancer
1 trial -
CIK
The First People's Hospital of Lianyungang
Lung Adenocarcinoma
1 trial -
CISPLATIN, CARBOPLATIN, KEYTRUDA 25 mg/mL concentrate for solution for infusion, CISPLATIN, FLUOROURACIL
Takeda
Solid Neoplasm
1 trial -
CISPLATIN, CARBOPLATIN, PACLITAXEL, PEMETREXED, LIBTAYO 350 mg concentrate for solution for infusion.
Talion
non-small cell lung cancer (NSCLC)
1 trial -
CISPLATIN, IMFINZI 50 mg/mL concentrate for solution for infusion., GEMCITABINE
The George Institute
Extrahepatic cholangiocarcinoma (eCCA)
1 trial -
CISPLATIN, Ipilimumab, PACLITAXEL, Nivolumab Subcutaneous, CARBOPLATIN, PEMETREXED
Bristol-Myers Squibb Australia Pty Ltd
Non-small cell lung cancer (NSCLC)
1 trial -
CISPLATIN, OPDIVO 10 mg/mL concentrate for solution for infusion., PACLITAXEL, anti-NKG2A mAb, CARBOPLATIN, PEMETREXED DISODIUM
Bristol-Myers Squibb Australia Pty Ltd
Non-small Cell Lung Cancer
1 trial -
CISPLATINE VIATRIS 25 mg/25 ml, solution à diluer pour perfusion, Tecentriq 1 200 mg concentrate for solution for infusion, CARBOPLATINE ACCORD 10 mg/ml, solution pour perfusion, Paclitaxel Accord Healthcare 6 mg/ml solution à diluer pour perfusion, KEYTRUDA 25 mg/mL concentrate for solution for infusion, ALIMTA 500 mg powder for concentrate for solution for infusion, OPDIVO 10 mg/mL concentrate for solution for infusion.
The George Institute
Patients with locally advanced or metastasic Non-Small Cell Lung Carcinoma.
1 trial -
CISPLATINO SANDOZ, LIBTAYO 350 mg concentrate for solution for infusion.
Fondazione Telethon ETS
locally advanced cervical carcinoma
1 trial -
CLN-081
Cullinan Therapeutics
Non Small Cell Lung Cancer
1 trial -
CLN-081, CLN-081
Cullinan Therapeutics
Non-Small Cell Lung Cancer Harboring EGFR Exon 20 Insertion Mutations
1 trial -
CM-24 and Nivolumab - Dose Escalation
PURPLE BIOTECH LTD.
Solid Tumor
1 trial -
CMB305
Lxo Ireland Designated Activity Company
Sarcoma
2 trials -
CMP-001
Regeneron UK Limited
Squamous Cell Carcinoma of Head and Neck
1 trial -
CNCT19
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Large B-cell Lymphoma
1 trial -
CORT125134, PACLITAXEL ALBUMIN-BOUND, BEVACIZUMAB, relacorilant
CORCEPT THERAPEUTICS INC
Gynecological Cancers
1 trial -
CPGJ602
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Metastatic Colorectal Cancer
2 trials -
CPX-1 (Irinotecan HCl:Floxuridine) Liposome Injection
Jazz Pharmaceuticals Ireland Limited
Colorectal Neoplasms
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Lymphoid Leukemia
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Leukemia, Myeloid, Acute
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Myeloid Neoplasm
1 trial -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia (AML)
2 trials -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia
7 trials -
CPX-351
Jazz Pharmaceuticals Ireland Limited
Acute Myeloid Leukemia (AML) in Remission
1 trial -
CR-001
CRESCENT BIOPHARMA, INC.
Locally Advanced / Metastatic Solid Tumors
1 trial -
CRB-601 monoclonal antibody
Corbus Pharmaceuticals Holdings
Solid Tumor
1 trial -
CRB-701
Corbus Pharmaceuticals Holdings
Solid Tumor, Adult
1 trial -
CRIZOTINIB, CRIZOTINIB, XALKORI 200 mg hard capsules, CRIZOTINIB, CRIZOTINIB, CRIZOTINIB, XALKORI 250 mg hard capsules, Torisel 30 mg concentrate and solvent for solution for infusion
Disc Medicine
Neuroblastoma (NBL), Rhabdomyosarcoma (RMS), Inflammatory Myofibroblastic Tumors (IMT), Other ALK/ROS1/MET-positive malignancies, Anaplastic Large Cell Lymphoma (ALCL)
1 trial -
CRN09682
Crinetics Pharmaceuticals Europe GmbH
SST2-positive Neuroendocrine Neoplasms
1 trial -
CS1001
Cstone Pharmaceuticals Ireland Limited
Advanced Refractory Solid Tumors
1 trial -
CT-011
Teva Pharma GmbH
Primary Hepatocellular Carcinoma
1 trial -
CT053PTSA
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Non-small Cell Lung Cancer
1 trial -
CT053PTSA
Sunshine Guojian Pharmaceutical (Shanghai) Co.,
Renal Cell Cancer Metastatic
1 trial -
CT7001, PF-07850327 round
Pfizer Australia Pty Ltd
Advanced or Metastatic Breast Cancer
1 trial -
CTX-009
Compass Therapeutics
Metastatic Colorectal Cancer
1 trial -
CTX-009 (ABL001)
Compass Therapeutics
P1b: Advanced Solid Tumors
1 trial -
CTX112
S.A.
B-cell Lymphoma
1 trial -
CTX131
S.A.
T Cell Lymphoma
1 trial -
CTX131
S.A.
Clear Cell Renal Cell Carcinoma
1 trial
Frequently asked questions
How many oncology Phase II programs exist?
2,640 programs match both the therapeutic area and stage filters in our published index.
Data attribution: Data sources · All pipeline programs